Lastly, a significant increase in ET-1 concentration after 6 months of follow-up that we found in SCH patients without levothyroxine therapy is probably due to low concentrations of measured ET-1 that turned out to be just statistically significant, and not clinically. This evidence concerns the gene EDN1 and spindle cell hemangioma.